Clinical Performance of High Viscosity Bioactive Injectable Composite in Deep Marginal Elevation
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-50
SponsorFuture University in Egypt
About this trial
Using a bioactive resin composite in subgingival Class II cavities can provide enhanced caries resistance by releasing multiple ions, including fluoride. This approach offers greater resistance to caries due to the incorporation of surface pre-reacted glass filler (S-PRG) technology (Imazato, Nakatsuka et al., 2023).
This type of composite may improve the outcomes of deep subgingival margin elevation, benefiting both restorative success and periodontal health.
Eligibility criteria
Qualifiers
Adult Patient (20-50 years old)
Good oral hygiene (plaque index 0 or 1)
Patient approval
Absence of parafunctional habits and/or bruxism
Disqualifiers
Patients with known allergic or adverse reaction to the tested materials.
Bad oral hygiene
Systematic disease that may affect participation.
Xerostomic patients.
Trial design
Treatments tested in this trial
- Beautifil F00
- G-aenial Universal Injectable Flowable Composite
Treatment groups
50 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov